Crescent Capital BDC (CCAP) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
Election of two Class I Directors to serve until the 2028 Annual Meeting, with nominees Kathleen S. Briscoe and George G. Strong, Jr.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
Additional business may be transacted as properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
Audit committee and external auditor matters
Ernst & Young LLP proposed for ratification as the external auditor for the 2025 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Crescent Capital BDC
- Q4 net investment income covered the dividend, with NAV at $19.10 and a defensively positioned portfolio.CCAP
Q4 202526 Feb 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025 - Q2 2025 delivered strong income, stable NAV, and a $20M share repurchase program.CCAP
Q2 202523 Nov 2025 - Net investment income steady at $0.46 per share; NAV and net income per share declined.CCAP
Q3 202517 Nov 2025